Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 1.61B INR in the quarter ending December 31, 2025, with 56.70% growth. This brings the company's revenue in the last twelve months to 5.91B, up 45.58% year-over-year. In the fiscal year ending March 31, 2025, Fredun Pharmaceuticals had annual revenue of 4.54B with 30.35% growth.

• Revenue (ttm): 5.91B
• Revenue Growth: +45.58%
• P/S Ratio: 1.46
• Revenue / Employee: 22.64M
• Employees: 261
• Market Cap: 8.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.54B	1.06B	30.35%
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%
Mar 31, 2021	1.34B	211.22M	18.74%